Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/177677
COMPARTIR / EXPORTAR:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Proinsulin therapy protects against neuroinflammaging and cognitive loss in senescence-accelerated mice

AutorSanfeliu, Coral CSIC ORCID; Corpas, Rubén CSIC ORCID; Hernández-Pinto, Alberto M. CSIC ORCID; Porquet, David CSIC; Hernández-Sánchez, Catalina ; Bosch, Fátima; Ortega-Aznar, Arantxa; Comellas, Francesc; De la Rosa, Enrique J. CSIC ORCID
Fecha de publicación16-oct-2017
CitaciónIUBMB Focused Meeting (2017)
ResumenChronic low-grade neuroinflammation is tightly associated with brain age-related changes and it is considered a crucial derangement that paves the way to neurodegeneration and dementia. Among other ailments, inflammation may lead to insulin resistance that is a risk factor for Alzheimer’s disease. In this scenario, the hormone precursor proinsulin may have a potential pharmacological use in preventing neuronal death. Proinsulin is a bioactive molecule regulating neural cell death in embryonic processes and it was proven neuroprotective in mouse models of retinal neurodegeneration. We aimed to prove the geroprotective effect of a chronic proinsulin treatment against neuroinflammaging and memory loss in the senescence-accelerated mouse SAMP8. We used a gene therapy procedure through peripheral muscle transduction with an adeno-associated viral vector bearing the human proinsulin gene (AAV-hPi) that yielded sustained release of proinsulin into the bloodstream. One-month old male mice of the SAMP8 strain and the control strain SAMR1 were injected with AAV-hPi or AAV-null vectors. At 6 months of age, proinsulin-treated SAMP8 mice showed totally preserved cognitive capacities both in spatial and recognition paradigms of learning and memory, in contrast to those SAMP8 mice injected with the null vector. Hippocampus analysis showed that proinsulin activated Akt and ATF1/CREB signaling pathways in both SAMR1 and SAMP8 mice. Furthermore, we identified a significant decrease of neuroinflammatory markers in the hippocampus of SAMP8 mice to levels of SAMR1 mice. Strikingly, the marker of astrocyte reactivity GFAP was decreased in both SAMR1 and SAMP8. Furthermore, the connectome network build with all changes induced by proinsulin showed that the decrease of astrocyte reactivity was a central effect in proinsulin neuroprotection. Therefore, the preventive and protective effects of human proinsulin against neuroinflammaging and senescence-related cognitive loss unveil a potential geroprotective therapy to increase healthy brain aging.
DescripciónTrabajo presentado en el IUBMB Focused Meeting on «Molecular aspects of aging and longevity», celebrado en Atenas, del 16 al 19 de octubre de 2017
URIhttp://hdl.handle.net/10261/177677
Aparece en las colecciones: (IIBB) Comunicaciones congresos
(CIB) Comunicaciones congresos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
Proinsulin_Sanfeliu.pdf1,21 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

Page view(s)

232
checked on 27-mar-2024

Download(s)

123
checked on 27-mar-2024

Google ScholarTM

Check


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.